ATENOLOL
Tracking # 20-841223
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
ATENOLOL IS A SECOND-GENERATION BETA-1-SELECTIVE ADRENERGIC ANTAGONIST INDICATED IN THE TREATMENT OF HYPERTENSION, ANGINA PECTORIS, AND ACUTE MYOCARDIAL INFARCTION. NON-FDA APPROVED INDICATIONS INCLUDE TREATMENT OF ARRHYTHMIAS, MIGRAINE PROPHYLAXIS, PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA, ALCOHOL WITHDRAWAL, THYROTOXICOSIS, AND PROPHYLAXIS AGAINST SECONDARY MYOCARDIAL INFARCTION. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, SAFE ADMINISTRATION, ADVERSE EFFECTS, CONTRAINDICATIONS, MONITORING, AND TOXICITY OF ATENOLOL.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I